Non-interventional Multi-center Study on Patients Under Routine Treatment of Pulmonary Arterial Hypertension (PAH) With Inhaled Iloprost Using I-Neb as a Device for Inhalation

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 23, 2013

Primary Completion Date

July 20, 2016

Study Completion Date

April 13, 2017

Conditions

Pulmonary Hypertension

Interventions

DRUG

Iloprost (Ventavis, BAYQ 6256)

Patients Diagnosed with Pulmonary Arterial Hypertension, Functional Class NYHA/WHO III, for whom was prescribed inhaled Iloprost.

Trial Locations (1)

Multiple Locations